Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants
Clinical trial NCT06045000 · COMPLETED
Trial details
- NCT number
- NCT06045000
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2023-10-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.